All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Renal function at two years in liver transplant patients receiving everolimus: Results of a randomized, multicenter study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F13%3A00058813" target="_blank" >RIV/00023001:_____/13:00058813 - isvavai.cz</a>

  • Result on the web

    <a href="http://onlinelibrary.wiley.com/doi/10.1111/ajt.12280/pdf" target="_blank" >http://onlinelibrary.wiley.com/doi/10.1111/ajt.12280/pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/ajt.12280" target="_blank" >10.1111/ajt.12280</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Renal function at two years in liver transplant patients receiving everolimus: Results of a randomized, multicenter study

  • Original language description

    In a 24-month prospective, randomized, multicenter, open-label study, de novo liver transplant patients were randomized at 30 days to everolimus (EVR)+Reduced tacrolimus (TAC; n=245), TAC Control (n=243) or TAC Elimination (n=231). Randomization to TAC Elimination was stopped prematurely due to a significantly higher rate of treated biopsy-proven acute rejection (tBPAR). The incidence of the primary efficacy endpoint, composite efficacy failure rate of tBPAR, graft loss or death postrandomization was similar with EVR+Reduced TAC (10.3%) or TAC Control (12.5%) at month 24 (difference -2.2%, 97.5% confidence interval [CI] -8.8%, 4.4%). BPAR was less frequent in the EVR+Reduced TAC group (6.1% vs. 13.3% in TAC Control, p=0.010). Adjusted change in estimated glomerular filtration rate (eGFR) from randomization to month 24 was superior with EVR+Reduced TAC versus TAC Control: difference 6.7mL/min/1.73m2 (97.5% CI 1.9, 11.4mL/min/1.73m2, p=0.002). Among patients who remained on treatment, me

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FJ - Surgery including transplantology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    American journal of transplantation

  • ISSN

    1600-6135

  • e-ISSN

  • Volume of the periodical

    13

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    12

  • Pages from-to

    1734-1745

  • UT code for WoS article

    000320928800017

  • EID of the result in the Scopus database